NCT04521868View on ClinicalTrials.gov

A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

August 12, 2022

Study Completion Date

August 12, 2022

Conditions
Schizophrenia
Interventions
DRUG

Sulforaphane

Sulforaphane is a compound that can be extracted from broccoli, Brussel sprouts, cabbage, and other cruciferous plants.

DIETARY_SUPPLEMENT

placebo

Placebo is made of starch

Trial Locations (1)

410008

Second Xiangya Hospital, Changsha

All Listed Sponsors
lead

Central South University

OTHER

NCT04521868 - A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients | Biotech Hunter | Biotech Hunter